article thumbnail

New Data Network Seeks to Provide Much-Needed Info on GLP-1s

MedCity News

OMNY Health — a national data ecosystem that facilitates biotech and medical research — launched a data network consisting of EHR data from more than 645,000 GLP-1 users. The post New Data Network Seeks to Provide Much-Needed Info on GLP-1s appeared first on MedCity News.

article thumbnail

Connect With More Than 100 Healthcare Startups at MedCity INVEST 2024!

MedCity News

Equal parts networking and curated panels covering the latest trends in healthcare investment, MedCity INVEST 2024 is the ideal event to discuss health tech, biopharma, devices and diagnostics investment opportunities. Register today!

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Biopharma could reap benefits from SVB UK acquisition

European Pharmaceutical Review

Impact of SVB UK acquisition on European biopharma companies One Netherlands-based biopharmaceutical company anticipated that the acquisition of SVP UK would allow access to its $19 million deposit and not experience losses, noted GlobalData.

article thumbnail

Eurofins BPT expands biopharma testing services in Canada

PharmaTech

EBPT Toronto expands Eurofins BioPharma Product Testing's North American presence, offering comprehensive product testing services in Toronto. It ensures consistent quality across its network, prioritizing customer satisfaction and regulatory compliance throughout the drug development process.

article thumbnail

Understanding the Impact of the Veradigm Network on Value-Based Healthcare Delivery

Pharmaceutical Commerce

Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.

article thumbnail

Sandoz to boost biosimilar development with manufacturing expansion

European Pharmaceutical Review

The company intends to grow its Biopharma Technical Development (BioTD) capabilities and transform the lab building into a state-of-the-art biotech lab by the last quarter of 2023. Sandoz has announced it is investing €25 million in its manufacturing site in Holzkirchen, Germany, to expand its biosimilar development capabilities.

article thumbnail

2024: A Pivotal Year in Curbing Pharmacy Costs

MedCity News

Concerns around potential antitrust issues are arising from the significant control held by the legacy PBMs and, in turn, the power of their vertically integrated networks. Legislators are calling for a closer look at the vertical consolidation of PBMs with carriers.